HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Mizuho Securities USA LLC

Mizuho Securities USA LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 43.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 17,285 shares of the company’s stock after purchasing an additional 5,236 shares during the quarter. Mizuho Securities USA LLC’s holdings in HCA Healthcare were worth $5,188,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Quantbot Technologies LP acquired a new position in HCA Healthcare during the fourth quarter worth $9,240,000. Millstone Evans Group LLC acquired a new position in shares of HCA Healthcare in the fourth quarter worth $126,000. Summit Global Investments raised its holdings in shares of HCA Healthcare by 387.6% in the fourth quarter. Summit Global Investments now owns 16,026 shares of the company’s stock worth $4,810,000 after acquiring an additional 12,739 shares during the last quarter. Adams Diversified Equity Fund Inc. raised its holdings in shares of HCA Healthcare by 63.0% in the fourth quarter. Adams Diversified Equity Fund Inc. now owns 49,700 shares of the company’s stock worth $14,917,000 after acquiring an additional 19,200 shares during the last quarter. Finally, TD Private Client Wealth LLC raised its holdings in shares of HCA Healthcare by 33.7% in the fourth quarter. TD Private Client Wealth LLC now owns 6,130 shares of the company’s stock worth $1,840,000 after acquiring an additional 1,545 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 1.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on HCA shares. Truist Financial cut their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Bank of America lowered their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Finally, KeyCorp lowered their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $329.25 on Friday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The business has a 50-day moving average of $321.50 and a 200-day moving average of $343.07. The company has a market capitalization of $81.06 billion, a price-to-earnings ratio of 14.99, a PEG ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the business earned $5.90 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.87%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is presently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.